
Rusco Pharma Private Limited
About Rusco Pharma Private Limited
Data last updated:
Rusco Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the real estate financing segment of the financial services sector. It was incorporated on 16 August 1994.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1994PTC080348. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Its last annual general meeting (AGM) was held on 27 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2016, the company reported a revenue of ₹1.02 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹49.08 Lakh (net margin 48.1%) and EBITDA of ₹77.29 Lakh (EBITDA margin 75.8%).
As per MCA filings, the company has satisfied charges of ₹7 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it.
Company details
Contact details
Rusco Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressGround Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Rusco Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rusco Pharma Private Limited
FY 2016 filings availableRusco Pharma Private Limited reported revenue of ₹1.02 Cr (up 2% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year. EBITDA fell 6% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹1.02 Cr | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹77.29 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹49.08 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 75.8% | |
| Net Profit Margin | 48.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rusco Pharma Private Limited, buy the company report.
Board of directors of Rusco Pharma Private Limited
Rusco Pharma has 6 former directors on record and no current directors listed.
Peer comparison
Rusco Pharma Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vikashni Builder Private Limited | ₹1.02 Cr (FY 2024) | 5.0% | Madurai, Tamil Nadu, India | |||
| Akash Deep Private Limited | ₹1.02 Cr (FY 2025) | 8.0% | Agra, Uttar Pradesh, India | |||
| Ridhima Overseas Private Limited | ₹1.02 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Kadamb Hotels Pvt Ltd | ₹1.02 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Goldstar Estates Private Limited | ₹1.02 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Rusco Pharma Private Limitedthis company | ₹1.02 Cr (FY 2016) | ₹49.08 Lakh | 48.1% | 2.0% | Mumbai, Maharashtra, India | |
| Garden City Foundation Private Limited | ₹1.02 Cr (FY 2025) | 121.0% | Bangalore, Karnataka, India | |||
| Good Earth Constructions Private Limited | ₹1.02 Cr (FY 2025) | 1034.0% | Uttar Pradesh, India | |||
| Amol Properties Private Limited | ₹1.02 Cr (FY 2025) | -94.0% | Jaipur, Rajasthan, India | |||
| Ipf Infrastructures Private Limited | ₹1.02 Cr (FY 2025) | 299.0% | Chandigarh, India | |||
| Gurmat Construction Company Private Limited | ₹1.02 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India |
To see the full peer comparison of Rusco Pharma Private Limited, buy the company report.
Auditor
Rusco Pharma Private Limited is audited by HEMANG & BHAVEN for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HEMANG & BHAVEN | FY 2016 | 126071W |
Shareholding
The shareholding of Rusco Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rusco Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Nov 2013 | 10461236 | Icici Bank Ltd | ₹7 Cr | Satisfied |
To see the full charge records of Rusco Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Rusco Pharma Private Limited has 7 court cases on record: 1 filed by Rusco Pharma, 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 6 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (4 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Appeal | Filed against the company by The Municipal Corporation of Greater Mumbai | Disposed |
| High Court, MAHARASHTRA | Court case (CAF) | Filed against the company by The Municipal Corporation of Greater Mumbai | Disposed |
| Bombay High Court | Court case (CAF) | Filed against the company by The Municipal Corporation of Greater Mumbai | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Rusco Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rusco Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rusco Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rusco Pharma Private Limited, buy the company report.
Recent activity
Rusco Pharma Private Limited has 6 board changes on record since 2008: 0 appointments and 6 cessations. The latest: Abhishek Saraf ceased to be Director on 08 Mar 2017.
Frequently asked questions
Rusco Pharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Rusco Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 16 August 1994 and is registered under CIN U24230MH1994PTC080348. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Rusco Pharma is U24230MH1994PTC080348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rusco Pharma was incorporated on 16 August 1994. It is registered with the Registrar of Companies, Mumbai.
The registered office of Rusco Pharma is at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9 – 11 Senapati Bapat Marg Lower, Mumbai, Maharashtra, India – 400013.
The latest financial statements of Rusco Pharma on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 27 September 2016. Year-wise statements from 2015 are in the company report.
No. Rusco Pharma has 1 GST registration on record and it is cancelled or inactive.
Rusco Pharma operated in the financial services industry, in the real estate financing segment.
The peers of Rusco Pharma by revenue are Vikashni Builder Private Limited, Akash Deep Private Limited, Ridhima Overseas Private Limited, Kadamb Hotels Pvt Ltd, Goldstar Estates Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).
Rusco Pharma has 7 court cases on record: 1 filed by the company and 6 filed against it. Most are in the high courts.
Abhishek Saraf ceased to be Director on 08 Mar 2017. Gaurav Saraf ceased to be Director on 08 Mar 2017. Motilal Saraf ceased to be Director on 08 Mar 2017. Rusco Pharma has 6 board changes on record in total.

